288 related articles for article (PubMed ID: 23300948)
1. Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement.
Donega V; van Velthoven CT; Nijboer CH; van Bel F; Kas MJ; Kavelaars A; Heijnen CJ
PLoS One; 2013; 8(1):e51253. PubMed ID: 23300948
[TBL] [Abstract][Full Text] [Related]
2. CXCL10 is a crucial chemoattractant for efficient intranasal delivery of mesenchymal stem cells to the neonatal hypoxic-ischemic brain.
Hermans EC; Donega V; Heijnen CJ; de Theije CGM; Nijboer CH
Stem Cell Res Ther; 2024 May; 15(1):134. PubMed ID: 38715091
[TBL] [Abstract][Full Text] [Related]
3. Intranasal administration of human MSC for ischemic brain injury in the mouse: in vitro and in vivo neuroregenerative functions.
Donega V; Nijboer CH; Braccioli L; Slaper-Cortenbach I; Kavelaars A; van Bel F; Heijnen CJ
PLoS One; 2014; 9(11):e112339. PubMed ID: 25396420
[TBL] [Abstract][Full Text] [Related]
4. Hypothermia combined with extracellular vesicles from clonally expanded immortalized mesenchymal stromal cells improves neurodevelopmental impairment in neonatal hypoxic-ischemic brain injury.
Labusek N; Ghari P; Mouloud Y; Köster C; Diesterbeck E; Hadamitzky M; Felderhoff-Müser U; Bendix I; Giebel B; Herz J
J Neuroinflammation; 2023 Nov; 20(1):280. PubMed ID: 38012640
[TBL] [Abstract][Full Text] [Related]
5. Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury.
Donega V; Nijboer CH; van Tilborg G; Dijkhuizen RM; Kavelaars A; Heijnen CJ
Exp Neurol; 2014 Nov; 261():53-64. PubMed ID: 24945601
[TBL] [Abstract][Full Text] [Related]
6. Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse.
Donega V; Nijboer CH; van Velthoven CT; Youssef SA; de Bruin A; van Bel F; Kavelaars A; Heijnen CJ
Pediatr Res; 2015 Nov; 78(5):520-6. PubMed ID: 26270577
[TBL] [Abstract][Full Text] [Related]
7. Interaction between hypothermia and delayed mesenchymal stem cell therapy in neonatal hypoxic-ischemic brain injury.
Herz J; Köster C; Reinboth BS; Dzietko M; Hansen W; Sabir H; van Velthoven C; Bendix I; Felderhoff-Müser U
Brain Behav Immun; 2018 May; 70():118-130. PubMed ID: 29454023
[TBL] [Abstract][Full Text] [Related]
8. Intranasal Delivery of Mesenchymal Stromal Cells Protects against Neonatal Hypoxic⁻Ischemic Brain Injury.
McDonald CA; Djuliannisaa Z; Petraki M; Paton MCB; Penny TR; Sutherland AE; Castillo-Melendez M; Novak I; Jenkin G; Fahey MC; Miller SL
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108944
[TBL] [Abstract][Full Text] [Related]
9. Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage.
van Velthoven CT; Kavelaars A; van Bel F; Heijnen CJ
Pediatr Res; 2010 Nov; 68(5):419-22. PubMed ID: 20639794
[TBL] [Abstract][Full Text] [Related]
10. Hypothermia broadens the therapeutic time window of mesenchymal stem cell transplantation for severe neonatal hypoxic ischemic encephalopathy.
Ahn SY; Chang YS; Sung DK; Sung SI; Park WS
Sci Rep; 2018 May; 8(1):7665. PubMed ID: 29769612
[TBL] [Abstract][Full Text] [Related]
11. Neural Stem Cells Expressing bFGF Reduce Brain Damage and Restore Sensorimotor Function after Neonatal Hypoxia-Ischemia.
Ye Q; Wu Y; Wu J; Zou S; Al-Zaazaai AA; Zhang H; Shi H; Xie L; Liu Y; Xu K; He H; Zhang F; Ji Y; He Y; Xiao J
Cell Physiol Biochem; 2018; 45(1):108-118. PubMed ID: 29316558
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of genetically modified mesenchymal stem cells after neonatal hypoxic-ischemic brain damage.
van Velthoven CT; Braccioli L; Willemen HL; Kavelaars A; Heijnen CJ
Mol Ther; 2014 Mar; 22(3):645-654. PubMed ID: 24172866
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration.
van Velthoven CT; Kavelaars A; van Bel F; Heijnen CJ
Brain Behav Immun; 2010 Mar; 24(3):387-93. PubMed ID: 19883750
[TBL] [Abstract][Full Text] [Related]
14. Intranasal administration of Cytoglobin modifies human umbilical cord‑derived mesenchymal stem cells and improves hypoxic‑ischemia brain damage in neonatal rats by modulating p38 MAPK signaling‑mediated apoptosis.
Yang H; Tian S; Xie L; Chen Y; Ma L
Mol Med Rep; 2020 Oct; 22(4):3493-3503. PubMed ID: 32945464
[TBL] [Abstract][Full Text] [Related]
15. Human pluripotent stem cell-derived ectomesenchymal stromal cells promote more robust functional recovery than umbilical cord-derived mesenchymal stromal cells after hypoxic-ischaemic brain damage.
Huang J; U KP; Yang F; Ji Z; Lin J; Weng Z; Tsang LL; Merson TD; Ruan YC; Wan C; Li G; Jiang X
Theranostics; 2022; 12(1):143-166. PubMed ID: 34987639
[No Abstract] [Full Text] [Related]
16. Delayed Double Treatment with Adult-Sourced Adipose-Derived Mesenchymal Stem Cells Increases Striatal Medium-Spiny Neuronal Number, Decreases Striatal Microglial Number, and Has No Subventricular Proliferative Effect, after Acute Neonatal Hypoxia-Ischemia in Male Rats.
Basham HK; Aghoghovwia BE; Papaioannou P; Seo S; Oorschot DE
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360638
[TBL] [Abstract][Full Text] [Related]
17. Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function.
van Velthoven CT; Kavelaars A; van Bel F; Heijnen CJ
J Neurosci; 2010 Jul; 30(28):9603-11. PubMed ID: 20631189
[TBL] [Abstract][Full Text] [Related]
18. Human Placenta-Derived Mesenchymal Stem Cells Improve Neurological Function in Rats with Intrauterine Hypoxic-Ischaemic Encephalopathy by Reducing Apoptosis and Inflammatory Reactions.
Zhao YQ; Xu YY; Zheng YM; Han F; Zhang Y; Pan RL; Chen JR; Hao YM; Yang LW
Front Biosci (Landmark Ed); 2024 Apr; 29(4):139. PubMed ID: 38682178
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem-cell transplantation for hypoxic-ischemic brain injury in neonatal rat model.
Lee JA; Kim BI; Jo CH; Choi CW; Kim EK; Kim HS; Yoon KS; Choi JH
Pediatr Res; 2010 Jan; 67(1):42-6. PubMed ID: 19745781
[TBL] [Abstract][Full Text] [Related]
20. Delayed administration of neural stem cells after hypoxia-ischemia reduces sensorimotor deficits, cerebral lesion size, and neuroinflammation in neonatal mice.
Braccioli L; Heijnen CJ; Coffer PJ; Nijboer CH
Pediatr Res; 2017 Jan; 81(1-1):127-135. PubMed ID: 27632779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
